John Paul II Hospital

Running trials

• Enrolling by invitation

  A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients

  NCT06445673· AOP Orphan Pharmaceuticals AG· Source

• Recruiting

  Evaluation of the Efficacy of Valsartan in Slowing Down Aortic Root Dilatation in Children and Young Adults with Marfan

  2024-515059-39-00· Phase 3· Medical University Of Gdansk· Source

• Recruiting

  Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation

  NCT06584266· University in Zielona Góra· Source

• Active, not recruiting

  TrEatment Approach in the Multimodal Era Registry

  NCT05629052· International CTEPH Association· Source

• Enrolling by invitation

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  NCT05667493· Phase 3· Ionis Pharmaceuticals, Inc.· Source

• Active, not recruiting

  Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)

  NCT05279651· Phase 3· Jagiellonian University· Source

• Recruiting

  Safety and Performance Study of the Optimum Transcatheter Aortic Valve

  NCT04076150· Thubrikar Aortic Valve, Inc.· Source

• Active, not recruiting

  COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events

  NCT05333068· Diagram B.V.· Source

• Recruiting

  Acute Stroke of CArotid Artery Bifurcation Origin Treated With Use oF the MicronEt-covered CGUARD (SAFEGUARD-STROKE)

  NCT05195658· John Paul II Hospital, Krakow· Source

• Recruiting

  TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Heart Failure

  NCT05250349· John Paul II Hospital, Krakow· Source

• Active, not recruiting

  Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism

  NCT04790370· Phase 4· Boston Scientific Corporation· Source

• Recruiting

  Simultaneous Cardiac Surgery and Micronet-covered Stent Carotid Revascularization in High Perioperative Stroke Risk Patients

  NCT04973579· John Paul II Hospital, Krakow· Source

• Recruiting

  LANDMARK Trial: a Randomised Controlled Trial of Myval THV

  NCT04275726· Meril Life Sciences Pvt. Ltd.· Source

• Enrolling by invitation

  Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH)

  NCT04545112· Xeltis· Source

• Active, not recruiting

  A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

  NCT04025879· Phase 3· Bristol-Myers Squibb· Source

• Recruiting

  DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL

  NCT03959748· Polish Cardiology Association· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure3 recruiting
• Stroke3 recruiting
• Aortic stenosis2 recruiting
• Coronary artery disease2 recruiting
• High blood pressure2 recruiting
• Pulmonary arterial hypertension2 recruiting
• Amyloidosis1 recruiting
• Atrial fibrillation1 recruiting
• Osteoarthritis1 recruiting

Closed trials

• Active, not recruiting

  A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

  NCT04819100· Phase 3· Eli Lilly and Company· Source

• Terminated

  Levosimendan In Ambulatory Heart Failure Patients

  NCT04705337· Phase 4· Medical University of Bialystok· Source

• Completed

  Evaluation of the Safety and Performance of Magneto PE Kit

  NCT04949048· Magneto Thrombectomy Solutions· Source

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source

• Terminated

  A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

  NCT04271475· Phase 3· Actelion· Source

• Completed

  Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)

  NCT03829332· Phase 3· Merck Sharp & Dohme LLC· Source

• Completed

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· Phase 3· CSL Behring· Source

• Completed

  Cryo Global Registry

  NCT02752737· Medtronic Cardiac Ablation Solutions· Source

• Completed

  A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation

  NCT02444338· University Medical Center Goettingen· Source

• Completed

  Drug-coated Balloon in de Novo Chronic Total Occlusions

  NCT05977842· National Institute of Cardiology, Warsaw, Poland· Source

• Completed

  ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)

  NCT01757665· Edwards Lifesciences· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Pulmonary arterial hypertension16 works · 4 trials
• Aortic stenosis13 works · 3 trials
• Antiphospholipid syndrome7 works · 0 trials